Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Bioheng Therapeutics | LinkedIn
Bioheng Biotech received orphan drug designation from U.S. FDA
BioHeng - 2026 Company Profile, Funding & Competitors - Tracxn
Bioheng Closes $15 Million Funding from Decheng Capital for CAR-T ...
Bioheng Therapeutics Wins Approval for CD7 UCAR-T Therapy in T-ALL/LBL
Bioheng Biotech to advance Allogeneic Immuno-Cell Therapies
Bioheng Therapeutics Receives FDA RPDD for Off‑The‑Shelf CAR‑T CTD402 ...
Bioheng Therapeutics rebrands to Imviva Biotech, expanding global reach ...
Bioheng Biotech received Orphan Drug Designation from the U.S. FDA for ...
Nanjing Bioheng Biotech Co., Ltd. (南京北恒生物科技有限公司) - 药物管线_专利_临床试验_投融营收_最新 ...
Chinese Biotech Start-Up BioHeng Raises $15M Series A Round – China ...
Bioheng Therapeutics 2026 Company Profile: Valuation, Funding ...
CTA101 / Nanjing Bioheng Biotech
Bioheng Biotech has positive CAR-T cell therapy results published
Bioheng to present RD06-03 data at ASCO 2025 | Imviva Biotech posted on ...
Allogeneic anti-CD7 CAR T-cell therapy(Nanjing Bioheng Biotech)) - Drug ...
Nanjing Bioheng Biotech Co., Ltd. - Drug pipelines, Patents, Clinical ...
Company: Bioheng Biotech
Lu Han - Co-founder & CEO - Bioheng Therapeutics | LinkedIn
Bioheng Therapeutics Announces FDA Clearance of IND Application for CD7 ...
Sherry Yang 杨晓玲 - Bioheng | 领英
Chen Jie - Chief Medical Officer of Bioheng | 领英
CAR-T Pioneer Carl June Will Lend Wisdom to Bioheng Biotech - BioSpace
Xiao Shi - Bioheng Therapeutics | 领英
Penn Medicine's Dr. Carl June to chair Nanjing Bioheng Biotech's ...
Wengang GE - Bioheng Therapeutics | 领英
China Digest: Bioheng snags $80m; 5Y Capital backs Chocday
Jung Hsuan (Kate) Chen - Bioheng Therapeutics | LinkedIn
Chinese Bioheng Biotech received ODD from the U.S. FDA
Top 43 Startups in Jiangsu in 2024
Bioheng's CD7 UCAR-T and Allogeneic HSCT Sequential Therapy Study ...
News-Bioheng Therapeutics
CTB001 received Orphan Drug Designation (ODD) from the U.S. FDA
FDA clears IND for Bioheng's CD7-targeted CART cell therapy | Mark ...
CAR-T：北恒生物BIOHENG - 知乎
What is Bioengineering? | BioEHS - YouTube
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with ...
Preliminary Safety, Efficacy, and Cellular Kinetics of CTA313, a CD19 ...
Allogeneic and other innovative chimeric antigen receptor platforms ...
Nanocages developed to deliver small interfering RNAs
佰鸿干细胞官网
10 companies based in Nanjing enter Hurun Global Cheetah Index 2023 ...
南京北恒生物科技有限公司 - 企查查
EHA 2025 | 北恒生物公布通用型CAR-T产品CTD402治疗R/R T-ALL/LBL患者的最新临床数据医药新闻-ByDrug-一站 ...
American - Exciting news from ACR Convergence 2025! Two groundbreaking ...
Su Wang on LinkedIn: The Center for Asian Health was honored to be a ...
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a ...
Bioengineering: Unlocking the secrets of human health
Renewable Hydrogen: BIOHGEN - Catagen
Company Overview - Shanghai BioEngine Sci-Tech Co., Ltd.
Fundamental Research & Transformation of New Drugs Roadshow Promote ...
#genscript #cart #fdaapproval #cancertherapy #regulatorysupport | GenScript
Decheng Capital
【Cell Research】浙江大学黄河/王东睿团队首次证明同种异体CD7-CAR-T细胞治疗恶性肿瘤的安全有效性-《转》译-转化医学网 ...
Bioengineering hi-res stock photography and images - Alamy
BPCA Elects New Chairman - The Broadsheet
Engineering Allogeneic CAR-T Cell Therapies | Imviva
Bioengineering: Unlocking mysteries, enabling impact - Bioengineering ...
Imviva Biotech | LinkedIn
Nanjing Bike Biotechnology Co., Ltd
Board of Directors - NUVATION BIO, INC.
必一·运动(B-Sports)官方网站
Top 40 Biopharma Startups in 2023
领航通用型CAR-T细胞赛道！金斯瑞生物和北恒生物达成战略合作
Octagon Capital
Willow Adkins on LinkedIn: Building the Backbone: T Cell Therapies Take ...
Evolution of cell & gene therapy in China: the case for universal CAR-T ...
Top 40 Biopharma Startups in 2024
The Bioengineering Technologies to Look Out for in the Next Decade ...
What Tools Do Bioengineers Use at Adriana Fishburn blog
STI College Valencia | Valencia
Claudin18.2 Proteins | ACROBiosystems
Asset:Biofuel Plant S: Junheng Biotech Puyang
BioBANG connected to the cogenerator of a biomethane plant
FDA grants orphan drug designation to CAR T-cell therapy for gastric cancer
Cell therapy weekly: Univercells and RoosterBio enter strategic ...
FDA grants orphan drug designation to CAR T-cell therapy for gastric ...
Kewei Xu posted on LinkedIn
Ming Gao on LinkedIn: #cd7ucart #biohengbiotech #cancerresearch # ...
金斯瑞-基因合成_引物合成_多肽合成_蛋白表达和抗体工程
What Is Bioengineering?
Congrats to Professor Xu! The groundbreaking research on Allogeneic ...
北恒生物：靶向CD7的通用型CAR-T产品I期临床结果发表_摩熵医药(原药融云)
Life Science Company News, Pharma, Biotechnology, Medical Device ...
Living power: advancing bio-hydrovoltaic energy systems | EurekAlert!
Bioengine Industries
Home - Bio Engineering
.jpg)
